Skip to main content
Have a personal or library account? Click to login
First case of vaccine derived poliovirus isolated from a patient with a primary immune deficiency in Sri Lanka Cover

First case of vaccine derived poliovirus isolated from a patient with a primary immune deficiency in Sri Lanka

Open Access
|Oct 2014

Abstract

Persons with primary immune deficiency disorders (PID) exposed to oral polio vaccine (OPV)) are at increased risk of vaccine-associated paralytic poliomyelitis (VAPP)  and prolonged excretion of vaccine-derived polioviruses (VDPVs)

VDPVs are identified by a genetic divergence of at least 1%, or with Poliovirus 2, at least 0.6% in the VP1 region from the parent Sabin strain. A potential source of VDPV is a person with PID who excretes vaccine-derived polioviruses (iVDPVs).  These viruses may occasionally cause paralytic disease in the patient with PID, but has not been reported to have caused outbreaks of paralysis in immunologically normal people

We report the first isolate of iVDPV in Sri Lanka from a child with severe combined immune deficiency (SCID).

DOI: http://dx.doi.org/10.4038/sljid.v4i2.6672

Sri Lankan Journal of Infectious Diseases 2014; Vol.4(2):115-118

Language: English
Page range: 115 - 117
Published on: Oct 29, 2014
Published by: Sri Lankan Society for Microbiology
In partnership with: Paradigm Publishing Services

© 2014 S Gunasena, R de Silva, D Ratnayake, C Kumarasiri, J Deshpande, published by Sri Lankan Society for Microbiology
This work is licensed under the Creative Commons License.